1611466-21-7

Basic information

• Product Name: C₄₅H₅₄O₈
• Synonyms: C₄₅H₅₄O₈
• CAS NO: 1611466-21-7
• Molecular Weight: 722.919
• Mol File: 1611466-21-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: C₄₅H₅₄O₈(CAS DataBase Reference)
• NIST Chemistry Reference: C₄₅H₅₄O₈(1611466-21-7)
• EPA Substance Registry System: C₄₅H₅₄O₈(1611466-21-7)

Safety Data

• Hazardous Substances Data: 1611466-21-7(Hazardous Substances Data)

Upstream product

• 1611465-61-2 O,O-dibenzyl-2-(benzyloxymethyl)-4-ibutyl-6-bromoresorcinol 
• 1611466-05-7 O,O-dibenzyl-2-(benzyloxymethyl)-4-ibutylresorcinol 
• 1611466-03-5 O,O-dibenzyl-4-i-butylresorcinol 
• 18979-62-9 4-isobutylbenzene-1,3-diol 
• 108-46-3 recorcinol 
• 1611465-60-1 C₂₉H₅₈O₆Si₂ 
• 1611465-59-8 C₃₉H₆₇NO₈Si₂ 
• 29048-54-2 1-(2,4-dihydroxyphenyl)-2-methyl-1-propanone 
• 1611465-91-8 C₃₁H₆₂O₆SSi₂ 

Downstream Products

• 1611466-11-5 C₂₄H₃₆O₈ 

Relevant articles and documents

Stereocontrol by quaternary centres: A stereoselective synthesis of (-)-luminacin D

Very high diastereoselectivity can be achieved by 1,3-chelation-controlled allylation of aldehydes that possess a non-chelating α-ether substituent, even if the α-position is a quaternary centre and/or a spiro-epoxide. This reaction was used as a key step in an enantioselective synthesis of the angiogenesis inhibitor luminacin D.